<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01143883</url>
  </required_header>
  <id_info>
    <org_study_id>Silverlon 108010</org_study_id>
    <nct_id>NCT01143883</nct_id>
  </id_info>
  <brief_title>Study Looking at the Effect of Silverlon on Post Operative Wound Infections</brief_title>
  <official_title>A Randomized Controlled Clinical Trial Evaluating the Efficacy of Silverlon® in Preventing Surgical Site Infection Following Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jorge Marcet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study is a prospective, randomized, controlled trial of patients undergoing
      elective colorectal surgical procedures that receive an abdominal skin incision of at least 6
      cm. Treatment with Silverlon® will be compared to standard postoperative dressings of 4x4
      Gauze and paper tape. Patients will be randomized with a 1:1 treatment allocation ratio to
      receive either 1) Silverlon® or 2) standard postsurgical dressing. Neither the Investigators
      nor the participants will be blinded to the treatment modality after randomization.

      Silver has long been known to have antimicrobial properties. It interacts with structural
      proteins and DNA, inhibiting bacterial replication and causing fatal structural changes
      within the cell wall. It has broad antimicrobial activities and unlike antibiotics, it is
      rarely associated with microbial resistance. Silverlon® is a silver-nylon dressing
      specifically designed for surgical wounds to prevent the development of surgical site
      infections. It is an easy to use product with no known microbial resistance or adverse
      effects. The efficacy of Silverlon® in preventing surgical site infections has been shown in
      several retrospective studies but as of yet has not been tested in a prospective fashion. The
      objective of this study is to perform a prospective, randomized, clinical trial directly
      comparing the incidence of surgical site infections in patients treated with Silverlon® to
      standard postoperative dressing following elective colorectal surgery
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical Site Infection</measure>
    <time_frame>Day of surgery up to 30 days post operatively</time_frame>
    <description>We will monitor the incision from the day of surgery to post operative day 30 to determine if the incision needs antibiotics.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Infections</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Silverlon Dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Silverlon(Cura Surgical, Geneva, IL) dressing is applied to the surgical wound postoperatively. This dressing is coated with silver nylon.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard plain gauze is used to dress the wound postoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Silverlon</intervention_name>
    <description>Silverlon dressings are gauze impregnated with silver ions</description>
    <arm_group_label>Silverlon Dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care Dressing</intervention_name>
    <description>Standard dry gauze dressing</description>
    <arm_group_label>Standard of Care Dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All patients undergoing elective colorectal surgery by a trained colorectal surgeon
             with an abdominal skin incision of at least 3 cm

          2. Patients that are willing and able to comply with the requirements of the protocol
             including follow-up requirements

          3. Patients willing and able to sign a study specific informed consent

        Exclusion Criteria:

          1. Patients that fail to meet the skin incision size criteria

          2. Patients with a known allergy to silver

          3. Patients less than 18 years of age

          4. Any contraindication to undergoing a surgical procedure under general anesthesia

          5. Patients with preoperative evidence of a current abdominal wall infection/surgical
             site infection from a previous laparotomy/laparoscopy

          6. Patients that have received antibiotic therapy within the week prior to surgery

          7. Patients with preoperative evaluation suggestive of an intra-abdominal process that
             would preclude full closure of the skin

          8. Patients with a previously placed anterior abdominal wall mesh that is not planned to
             be completely removed during the planned procedure

          9. Women who are pregnant or breast feeding or are considering becoming pregnant during
             the follow-up period

         10. Mental incompetence as determined by the Investigator which would affect participation
             in the study

         11. Concurrently participating in any other investigational study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tampa General Hospital and University of South Florida Medical Clinics</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2010</study_first_submitted>
  <study_first_submitted_qc>June 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2010</study_first_posted>
  <results_first_submitted>December 10, 2012</results_first_submitted>
  <results_first_submitted_qc>June 11, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 13, 2013</results_first_posted>
  <last_update_submitted>June 11, 2013</last_update_submitted>
  <last_update_submitted_qc>June 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of South Florida</investigator_affiliation>
    <investigator_full_name>Jorge Marcet</investigator_full_name>
    <investigator_title>Professor, Department of Surgery</investigator_title>
  </responsible_party>
  <keyword>All patients undergoing a colorectal resection</keyword>
  <keyword>surgical site infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All 110 patients were consented for this study during their pre-operative visit.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Silverlon Dressing</title>
          <description>The Silverlon(Cura Surgical, Geneva, IL) dressing is applied to the surgical wound postoperatively. This dressing is coated with silver nylon.</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care Dressing</title>
          <description>The standard plain gauze is used to dress the wound postoperatively</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Silverlon Dressing</title>
          <description>55</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care Dressing</title>
          <description>55</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="55"/>
            <count group_id="B2" value="55"/>
            <count group_id="B3" value="110"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" spread="15.6"/>
                    <measurement group_id="B2" value="58" spread="11.1"/>
                    <measurement group_id="B3" value="60" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Surgical Site Infection</title>
        <description>We will monitor the incision from the day of surgery to post operative day 30 to determine if the incision needs antibiotics.</description>
        <time_frame>Day of surgery up to 30 days post operatively</time_frame>
        <population>The number of participants analyzed was based on the number who received treatment according to their randomized group and were treated according to study protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Silverlon Dressing</title>
            <description>55</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care Dressing</title>
            <description>55</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Site Infection</title>
          <description>We will monitor the incision from the day of surgery to post operative day 30 to determine if the incision needs antibiotics.</description>
          <population>The number of participants analyzed was based on the number who received treatment according to their randomized group and were treated according to study protocol</population>
          <units>percentage of participants with SSI</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Silverlon Dressing</title>
          <description>55</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care Dressing</title>
          <description>55</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1.82</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <description>Rash resolved after dressing removed</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Members of the surgical team were not blinded to the treatment group.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jorge E. Marcet, M.D.</name_or_title>
      <organization>University of South Florida</organization>
      <phone>813-844-4545</phone>
      <email>jmateka@health.usf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

